AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Long Term Provisions | ₹283 Cr | ₹226 Cr | ₹173 Cr | ₹172 Cr | ₹157 Cr |
What is the latest Long Term Provisions ratio of AUROBINDO PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2025 | ₹283 Cr |
Mar2024 | ₹226 Cr |
Mar2023 | ₹173 Cr |
Mar2022 | ₹172 Cr |
Mar2021 | ₹157 Cr |
How is Long Term Provisions of AUROBINDO PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2025 | ₹283 Cr | 25.36 | |
Mar2024 | ₹226 Cr | 30.67 | |
Mar2023 | ₹173 Cr | 0.54 | |
Mar2022 | ₹172 Cr | 9.34 | |
Mar2021 | ₹157 Cr | - |
Compare Long Term Provisions of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹60,658.8 Cr | 1.8% | -3.3% | -33.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,622.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,536.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
CIPLA | ₹125,468.0 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,162.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,874.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 1.8% |
-3.3% |
-33.2% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses